Increased CETP-activity has been observed in patients with type 1 diabetes and plasma APOC1 concentrations correlated inversely with CETP-activity in normoglycemic-normolipidemic controls but not in individuals with type 1 diabetes, indicating that APOC1 activity could be compromised in this population31. The gene discussed is APOC1; the disease is type 1 diabetes mellitus.